AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

ZOFENOPRIL

7 registrations across 3 African markets— 5 active

Markets with ZOFENOPRIL

🇺🇬Uganda
4 registrations
4 active
🇹🇳Tunisia
2 registrations
0 active
🇹🇿Tanzania
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
ZANTIPRES
Comprimé pelliculé / 7.5 mg
🇹🇳TunisiaF.I.R.M.A S.p.AexpiredJan 2017
ZANTIPRES
Comprimé pelliculé / 30 mg
🇹🇳TunisiaF.I.R.M.A S.p.AexpiredMar 2014
ZOFENOPRIL
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.active—
ZOFENOPRIL
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.active—
ZOFENOPRIL
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.active—
ZOFENOPRIL
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.active—
bifril
Tablets
🇹🇿TanzaniaMenarini International Operations Luxembourg S.Aactive—

ZOFENOPRIL in Africa — Regulatory Overview

ZOFENOPRIL is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Tunisia, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 5 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.